Greffex

Greffex

Biotechnology, East Montview BLVD, Aurora, , 80045, Colorado, 12635, United States, 11-50 Employees

greffex.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +17*********

Who is GREFFEX

GreffexTM is a privately held, multi-national company, headquartered in Aurora, Colorado. Established in 1999, Greffex has developed a novel genetic platform for the development and produ...

Read More

map
  • 12635 East Montview BLVD, Aurora, Colorado, 80045, United States Headquarters: 12635 East Montview BLVD, Aurora, Colorado, 80045, United States
  • 1999 Date Founded: 1999
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 621511 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GREFFEX

Greffex Org Chart and Mapping

Employees

Zebulyn Jones

Research and Development Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Greffex

Answer: Greffex's headquarters are located at East Montview BLVD, Aurora, , 80045, Colorado, 12635, United States

Answer: Greffex's phone number is +17*********

Answer: Greffex's official website is https://greffex.com

Answer: Greffex's revenue is $1 Million to $5 Million

Answer: Greffex's SIC: 2834

Answer: Greffex's NAICS: 621511

Answer: Greffex has 11-50 employees

Answer: Greffex is in Biotechnology

Answer: Greffex contact info: Phone number: +17********* Website: https://greffex.com

Answer: GreffexTM is a privately held, multi-national company, headquartered in Aurora, Colorado. Established in 1999, Greffex has developed a novel genetic platform for the development and production of vaccines. Our proprietary GREVAXTM Universal Platform delivers vaccines in a faster, more affordable and more efficient manner. Once a pathogen has been identified, Greffexs team designs and produces a GREVAXTM vaccine in as little as 4 weeks. The state-of-the-art flexibility of the GREVAXTM Universal Platform makes it the ideal delivery vehicle for vaccines against a wide variety of infectious disease, including but not limited to Pandemic Influenza strains, Anthrax and Dengue Fever, as well as Malaria, Hepatitis C, Respiratory Syncytial Virus (RSV), Ebola, HPV, Plague, Tuberculosis and a host of other vaccine candidates.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access